Regeneus
(ASX:RGS)

Regeneus Ltd (ASX: RGS) is an Australian clinical-stage regenerative medicine company developing a portfolio of innovative cellular therapies targeting significant unmet medical needs with a licence driven strategy.

Latest Article

Can This ASX Junior Surge Through the Pain Barrier?

Can This ASX Junior Surge Through the Pain Barrier?

Biotech company Regeneus (ASX:RGS) is a regenerative medicine company, and the therapy is a novel stem cell therapy.

Thanks for subscribing!

X